Cencora Inc., US15135B1017

Cencora Stock - chart picture and 200-day line on Thursday

18.06.2026 - 18:11:32 | ad-hoc-news.de

Cencora stock trades well above its 200-day moving average on the New York Stock Exchange. On this technical-focused Thursday, investors are watching chart levels, recent volatility and the broader healthcare distributor peer group rather than fresh corporate headlines.

Cencora Inc., US15135B1017
Cencora Inc., US15135B1017

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 18:09 CET. Details in the imprint.

Cencora Inc. (US15135B1017) is trading in a solid uptrend on the New York Stock Exchange. With no new company announcement or analyst rating change confirmed today, the focus turns to the Thursday technical picture and how the stock behaves around key moving averages.

Go deeper

All news and data on Cencora stock

Follow current disclosures, quotes and background reports on Cencora stock in one place on ad-hoc-news.de and via the company’s own investor relations pages.

What the latest chart data shows

According to MarketBeat data, Cencora shares closed at $277.10 on the New York Stock Exchange on 06/17/2026, after a decline of 1.55% on the day. In premarket extended trading, the quote was indicated at $270.44, 2.40% lower than the official close.

The stock has traded in a 52-week range between roughly $210 and $310, indicating a broad but still orderly corridor for investors. This band frames the current level in the upper half of the yearly range, consistent with a longer-running uptrend in the healthcare distribution space.

Focus on the 200-day moving average

Based on standard chart services tracking the New York listing, Cencora currently trades clearly above its 200-day moving average, which lies in the mid-$240s area as of mid-June 2026. The distance to this long-term line underpins a positive primary trend, even after short-term pullbacks.

On a Thursday technical read, traders also watch the 50-day moving average, positioned around the high-$260s, which has recently acted as a first dynamic support zone during minor corrections. Volatility remains moderate compared with many growth stocks, reflecting the more defensive character of healthcare distributors.

How Cencora makes its money

Cencora is a major pharmaceutical and healthcare products distributor, formerly known as AmerisourceBergen, and operates primarily in North America and Europe. The group earns most of its revenue by purchasing medicines and related products from manufacturers and supplying them to pharmacies, hospitals and other care providers.

Where the stock trades today

The shares of Cencora (US15135B1017) trade on the New York Stock Exchange at $277.10 as of 06/17/2026, 15:59 Eastern Time.

Cencora at a glance

  • Company: Cencora Inc.
  • ISIN: US15135B1017
  • WKN: A3EVN0
  • Ticker: COR
  • Venue: NYSE
  • Price (as of 06/17/2026, 15:59 Eastern Time): 277.10 USD
  • Market cap: approximately 55,000,000,000 USD (as of 06/17/2026)
  • Sector / Industry: Health Care / Pharmaceutical Distribution
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on Cencora stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US15135B1017 | CENCORA INC. | boerse | 69574546 | bgmi